Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,749 | 104,055 | 147,528 | 106,046 | 100,348 |
| TOTAL | $107,393 | $106,470 | $149,897 | $108,752 | $101,725 |
| Non-Current Assets | |||||
| PPE Net | 141 | 52 | 113 | 168 | 154 |
| Other Non-Current Assets | 1,833 | 965 | 1,318 | 549 | 319 |
| TOTAL | $1,974 | $1,017 | $1,431 | $717 | $473 |
| Total Assets | $109,367 | $107,487 | $151,328 | $109,469 | $102,198 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,158 | 2,205 | 1,019 | 1,287 | 1,339 |
| Accrued Expenses | 10,726 | 7,148 | 7,170 | 8,812 | 6,133 |
| Other current liabilities | N/A | N/A | 56,420 | N/A | N/A |
| TOTAL | $12,884 | $9,353 | $64,609 | $10,099 | $7,472 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,891 | N/A |
| Other Non-Current Liabilities | 485 | 175 | 374 | 0 | 0 |
| TOTAL | $485 | $175 | $374 | $4,891 | $N/A |
| Total Liabilities | $13,369 | $9,528 | $64,983 | $14,990 | $7,472 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,665 | 11,628 | 10,396 | N/A | N/A |
| Common Shares | 16 | 11 | 74 | 74 | 52 |
| Retained earnings | -941,248 | -846,589 | -765,687 | -677,412 | -624,077 |
| TOTAL | $95,998 | $97,959 | $86,345 | $94,479 | $94,726 |
| Total Liabilities And Equity | $109,367 | $107,487 | $151,328 | $109,469 | $102,198 |